BNO 0.00% 1.0¢ bionomics limited

Ann: BNC105 Enhances Efficacy of Immuno-Oncology Therapies, page-3

  1. 5,840 Posts.
    lightbulb Created with Sketch. 243
    "97% tumour inhibition demonstrated in colorectal cancer models"
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.